DIAGNOS (CVE:ADK) Reaches New 12-Month High – Time to Buy?

DIAGNOS Inc. (CVE:ADK)’s stock price hit a new 52-week high on Wednesday . The company traded as high as C$0.45 and last traded at C$0.44, with a volume of 236448 shares changing hands. The stock had previously closed at C$0.41.

DIAGNOS Trading Up 7.3%

The business’s fifty day moving average is C$0.29 and its two-hundred day moving average is C$0.27. The firm has a market cap of C$52.98 million, a price-to-earnings ratio of -11.00 and a beta of -0.14. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05.

Insider Activity at DIAGNOS

In other DIAGNOS news, Director Robert Dunn purchased 200,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The stock was acquired at an average cost of C$0.30 per share, with a total value of C$60,000.00. Following the completion of the purchase, the director directly owned 2,117,778 shares in the company, valued at approximately C$635,333.40. This represents a 10.43% increase in their position. In the last ninety days, insiders have purchased 328,571 shares of company stock worth $96,000. 16.81% of the stock is owned by insiders.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.